Tech Company Financing Transactions
Atterx BioTherapeutics Funding Round
Private investors invested in a $595 thousand venture round for Atterx BioTherapeutics. The round was announced by the company on 12/5/2013.
Transaction Overview
Company Name
Announced On
12/5/2013
Transaction Type
Debt
Amount
$595,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
505 South Rosa Rd. 29
Madison, WI 53719
USA
Madison, WI 53719
USA
Phone
Website
Email Address
Not Recorded
Overview
Proprietary products for the prevention and treatment of multi-drug resistant Gram negative bacterial infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Paul Evans
Chief Executive Officer
Steven Watt
Chief Financial Officer
James Millar
Chief Medical Officer
Lisa Ferstenberg
Browse more venture capital transactions:
Prev: 12/5/2013: Disruptor Beam venture capital transaction
Next: 12/5/2013: AcousticEye venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document tech company VC transactions. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs